Article info

Download PDFPDF
Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?
  1. Correspondence to Dr Alec Miners, Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SY, UK; alec.miners{at}lshtm.ac.uk
View Full Text

Citation

Miners A
Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?

Publication history

  • Accepted December 23, 2013
  • First published January 15, 2014.
Online issue publication 
February 12, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.